Literature DB >> 20964178

Special report: workshop on 4D-treatment planning in actively scanned particle therapy--recommendations, technical challenges, and future research directions.

Antje Knopf1, Christoph Bert, Emily Heath, Simeon Nill, Kim Kraus, Daniel Richter, Eugen Hug, Eros Pedroni, Sairos Safai, Francesca Albertini, Silvan Zenklusen, Dirk Boye, Matthias Söhn, Martin Soukup, Benjamin Sobotta, Antony Lomax.   

Abstract

This article reports on a 4D-treatment planning workshop (4DTPW), held on 7-8 December 2009 at the Paul Scherrer Institut (PSI) in Villigen, Switzerland. The participants were all members of institutions actively involved in particle therapy delivery and research. The purpose of the 4DTPW was to discuss current approaches, challenges, and future research directions in 4D-treatment planning in the context of actively scanned particle radiotherapy. Key aspects were addressed in plenary sessions, in which leaders of the field summarized the state-of-the-art. Each plenary session was followed by an extensive discussion. As a result, this article presents a summary of recommendations for the treatment of mobile targets (intrafractional changes) with actively scanned particles and a list of requirements to elaborate and apply these guidelines clinically.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20964178     DOI: 10.1118/1.3475944

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  12 in total

1.  4D Cone-beam CT reconstruction using a motion model based on principal component analysis.

Authors:  David Staub; Alen Docef; Robert S Brock; Constantin Vaman; Martin J Murphy
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Four-dimensional layer-stacking carbon-ion beam dose distribution by use of a lung numeric phantom.

Authors:  Shinichiro Mori; Motoki Kumagai; Kentaro Miki
Journal:  Radiol Phys Technol       Date:  2015-04-02

Review 3.  Current status and future prospects of multi-dimensional image-guided particle therapy.

Authors:  Shinichiro Mori; Silvan Zenklusen; Antje-Christin Knopf
Journal:  Radiol Phys Technol       Date:  2013-02-19

Review 4.  Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview.

Authors:  Radhe Mohan; Indra J Das; Clifton C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-10-01       Impact factor: 7.038

5.  Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Authors:  Chenbin Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Shawn Korte; Jiajian Shen; Xiaoning Ding; Yanle Hu; Yixiu Kang; Sameer R Keole; Terence T Sio; William W Wong; Narayan Sahoo; Martin Bues; Wei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

Review 6.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

7.  Digital reconstructed radiography with multiple color image overlay for image-guided radiotherapy.

Authors:  Shinichi Yoshino; Kentaro Miki; Kozo Sakata; Yuko Nakayama; Kouichi Shibayama; Shinichiro Mori
Journal:  J Radiat Res       Date:  2015-02-11       Impact factor: 2.724

Review 8.  Advances in 4D treatment planning for scanned particle beam therapy - report of dedicated workshops.

Authors:  Christoph Bert; Christian Graeff; Marco Riboldi; Simeon Nill; Guido Baroni; Antje-Christin Knopf
Journal:  Technol Cancer Res Treat       Date:  2013-12-17

9.  Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy.

Authors:  Paul Morel; Xiaodong Wu; Guillaume Blin; Stéphane Vialette; Ryan Flynn; Daniel Hyer; Dongxu Wang
Journal:  Front Oncol       Date:  2015-05-28       Impact factor: 6.244

Review 10.  Particle therapy in Europe.

Authors:  Cai Grau; Marco Durante; Dietmar Georg; Johannes A Langendijk; Damien C Weber
Journal:  Mol Oncol       Date:  2020-04-22       Impact factor: 7.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.